SeQure Dx
Waltham
About SeQure Dx
SeQure Dx provides safety data for on and off-target CRISPR gene editing therapies
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $17.5M
- Funding stage: M&A
- Last round: Series A (Apr 2021)
- Website: sequre-dx.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Commercial
Social Profiles
Canonical: https://fsome.com/organization/sequre-dx-93489 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.